drugset / Trial / NCT00741897
Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis
NaSingle-groupOpen-labelTreatment
Summary
To determine the safety and efficacy of Fexofenadine (Telfast®) 30mg pediatric tablets on Filipino children aged 6 to 11 for the relief of symptoms associated with perennial and intermittent allergic rhinitis.
Timeline
- Start
- 2002-03
- Primary completion
- 2003-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | 30 mg | — |